Home / Resource Library / Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic Leukemia

Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic Leukemia

Results of a phase II trial investigating lenalidomide for treatment of CLL.